Pulike Biological Engineering

Pulike Biological Engineering Gross Margin

The Gross Margin of Pulike Biological Engineering (603566.SS) as of Nov 5, 2026 is 59.87 %. In the previous year, Gross Margin was 61.09 % — a change of -2.00% (lower).

Gross Margin

59.87 %

YoY

-2.00%

Last updated:

Gross Margin of Pulike Biological Engineering is 2025 59.87 % . Gross Margin of Pulike Biological Engineering was 2024 61.09 % . It decreases by -2.00% lower compared to the previous year.

Pulike Biological Engineering's gross margin stands at 59.9%, down from 65.4% several years earlier.

The Pulike Biological Engineering Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
67.07 CNY
Jan 1, 2019
61.15 CNY
Jan 1, 2020
64.33 CNY
Jan 1, 2021
65.41 CNY
Jan 1, 2022
62.63 CNY
Jan 1, 2023
61.01 CNY
Jan 1, 2024
61.09 CNY
Jan 1, 2025
59.87 CNY
The Pulike Biological Engineering Gross Margin history
YEARGross MarginYoY
59.87 %-2.00%
61.09 %+0.13%
61.01 %-2.58%
62.63 %-4.26%
65.41 %+1.69%
64.33 %+5.19%
61.15 %-8.82%
67.07 %-1.81%
68.31 %-4.12%
71.24 %-2.04%
72.73 %-2.80%
74.82 %+10,101.07%
0.73 %+3.38%
0.71 %+2.53%
0.69 %-2.99%
0.71 %-1.38%
0.72 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc generates revenue through the research, development, manufacturing, and sale of veterinary biological products and chemical medicines. The company produces vaccines and antibodies for preventing and controlling epidemic diseases in poultry and livestock, alongside chemical medicines used in treating such diseases. Its primary customers are animal health providers and agricultural enterprises requiring disease prevention and treatment solutions for poultry and livestock. The business focuses on the veterinary biological products segment, including vaccines and antibodies, and the chemical medicines segment for livestock and poultry health management. The company's product portfolio includes veterinary biological products such as vaccines and antibodies, which are applied in the prevention and control of infectious diseases in poultry and livestock. Chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. Pulike Biological Engineering Inc targets agricultural enterprises and animal health sectors as key market segments, delivering solutions for disease management in the livestock and poultry industries. Pulike Biological Engineering Inc's revenue streams are derived from the sale of veterinary biological products and chemical medicines. The company's veterinary biological products segment encompasses vaccines and antibodies for preventing and controlling infectious diseases in poultry and livestock. Chemical medicines are sold for treating epidemic diseases in the same sectors. The business serves agricultural enterprises and animal health providers seeking comprehensive disease management solutions for poultry and livestock health. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

Gross Margin of Pulike Biological Engineering is 59.87 % in 2025.

Gross Margin of Pulike Biological Engineering changed from 61.09 % to 59.87 %, representing a -2.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Pulike Biological Engineering with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Pulike Biological Engineering

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Pulike Biological Engineering